Skip to content

Effect of Duramesh™ on Hernia Formation After Ileostomy Closure

Effect of Duramesh™ on Hernia Formation After Ileostomy Closure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06511414
Enrollment
106
Registered
2024-07-22
Start date
2024-01-03
Completion date
2026-12-01
Last updated
2026-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileostomy - Stoma, Incisional Hernia

Keywords

duramesh,

Brief summary

Diverting ileostomy is frequently utilized to protect high-risk anastomoses, though it is not shown to reduce the leak rate it may reduce the severe consequences of an anastomotic leak. Ileostomy will be reversed with restoration of continuity in majority of patients. Stoma site incisional hernias after ileostomy closure are complex hernias that can be associated with abdominal pain, discomfort, and a diminished quality of life. Duramesh™ non-absorbable polypropylene suture is a hollow core, microporous, cylindrical suture made off in polypropylene filaments that are loosely braided and bonded to each other with heat and pressure. The Aim of this study is to evaluate Duramesh™ suture vs standard closure on rates of hernia formation after ileostomy closure.

Interventions

DEVICEduramesh

Duramesh™ non-absorbable polypropylene suture is a hollow core, microporous, cylindrical suture made off in polypropylene filaments that are loosely braided and bonded to each other with heat and pressure

DEVICEControl

standard closure of fascia

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* • Patients undergoing ileostomy closure after surgery for cancer All patients with a stoma (independent of diagnosis) * Age 18 or greater * Surgical oncology patient where routine radiologic surveillance for malignancy is planned * Patient accepts participation and gives informed consent

Exclusion criteria

* • Pregnancy * Prior mesh hernia repair at laparotomy site * Life expectancy less than 1 years * Patient is unable / unwilling to provide informed consent * Patient is unable to comply with the protocol or proposed follow-up visits * Patient is enrolled in another hernia study * Non-English-speaking participants * Data from children will not analyzed in this study. * Cognitively Impaired Adults: Data from cognitively impaired adults will not analyzed in this study. * Adults Unable to Consent: Data from adults unable to consent will not analyzed in this study.

Design outcomes

Primary

MeasureTime frameDescription
hernia rates1 yearCompare hernia rates after ileostomy closure between Duramesh™ and standard monofilament closure

Secondary

MeasureTime frameDescription
infection rate1 yearEvaluate potential side effects including infections and need for re intervention associated with Duramesh™ vs standard closure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 28, 2026